VVUS

VVUS Articles

ThinkstockAugust 13, 2014: Stocks making new 52-week lows today included the following four firms. Cree Inc. (NASDAQ: CREE) saw shares fall more than 10% to a new 52-week low of $44.11 Wednesday...
ThinkstockVIVUS Inc. (NASDAQ: VVUS) investors have a lot to be disappointed about these days. America’s ballooning waistline is reaching a critical level, yet VIVUS did not even manage to close up...
ThinkstockVIVUS Inc. (NASDAQ: VVUS) is going to have to explain how its diet pill Qsymia had lower prescription volumes sequentially. If you just look at the revenue number, it looks massively higher...
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, April 3, 2014. They include Apple, Intel, Chevron, Exxon, Qualcomm and Citigroup.
ThinkstockVIVUS Inc. (NASDAQ: VVUS) is suffering from what looked like good news on the surface. The reality, and the catch about investing, is that things can often be much more complicated than an...
24/7 Wall St. has seen a marked increase in the number of stocks being cut to Underperform or Sell, and some of them have been the darlings of momentum traders for the past couple of years. Here is...
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 25, 2014. They include Tesla Motors, Verizon Communication and VIVUS.
ThinkstockThe biotech market has been on fire this year, and there is every indication that things will continue. With huge binary events right around the corner, and many of the top companies with...
ThinkstockPlease note that this article has been updated to account for deletions and updates on the list of stocks that could double. The bull market run in 2013 was so strong that many analysts and...
Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we focused on the quality large cap names and the stocks with the highest upside to their target...
The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.
Jon OggThis week marks the last one of major earnings reports, and both the DJIA and S&P 500 Index have recently challenged new all-time highs. Investors and traders have to wonder which stocks...
Jon OggWith the government shut down and with the debt ceiling debate breathing down everyone’s neck, investors have to be wondering what they should buy, sell and hold (or even avoid). Stocks have...
Jon OggInvestors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not get to see is when analyst downgrade stocks to sell or to avoid. 24/7...
U.S. equity markets opened lower this morning on relatively little economic data. In Europe, Germany reported that industrial production rose 1.2%, while a house price index in the U.K.rose 1.1%...